{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:18:57Z","timestamp":1747156737968,"version":"3.40.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.canrad.2024.05.007","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T12:23:43Z","timestamp":1732191823000},"page":"677-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is hypofractionated radiotherapy used to treat soft tissue sarcomas? Assessment of practices using the NETSARC network"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8843-2863","authenticated-orcid":false,"given":"Emma","family":"Agnoux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00efs","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassim","family":"Sahki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9milie","family":"Meknaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Jolnerovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2024.05.007_bib0260","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/j.canrad.2016.07.028","article-title":"[Radiotherapy of adult soft tissue sarcoma]","volume":"20","author":"Le P\u00e9choux","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2024.05.007_bib0265","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial","volume":"359","author":"O'Sullivan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2024.05.007_bib0270","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","article-title":"Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma","volume":"75","author":"Davis","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0275","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.prro.2020.04.003","article-title":"ASTRO radiation therapy summary of the ASCO-ASTRO-SSO Guideline on management of hereditary breast cancer","volume":"10","author":"Trombetta","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1667\/RADE-20-00226.1","article-title":"Cellular radiosensitivity of soft tissue sarcoma","volume":"196","author":"Haas","year":"2021","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2024.05.007_bib0290","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0360-3016(86)90081-7","article-title":"Tumor radioresponsiveness versus fractionation sensitivity","volume":"12","author":"Thames","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2024.05.007_bib0295","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tipsro.2019.10.003","article-title":"Patterns of practice of adaptive re-planning for anatomic variances during cone-beam CT guided radiotherapy","volume":"12","author":"Stankiewicz","year":"2019","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0300","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ijrobp.2017.12.262","article-title":"Association between treatment at high-volume facilities and improved overall survival in soft tissue sarcomas","volume":"100","author":"Venigalla","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2024.05.007_bib0305","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3389\/fonc.2020.00993","article-title":"Coronavirus Disease (COVID-19) Outbreak: Hypofractionated radiotherapy in soft tissue sarcomas as a valuable option in the environment of limited medical resources and demands for increased protection of patients","volume":"10","author":"Spa\u0142ek","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0310","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00066-017-1115-z","article-title":"Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy: Results of a single, institutional, retrospective study","volume":"193","author":"Rudat","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0315","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.12430","article-title":"Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer","volume":"27","author":"Zempl\u00e9nyi","year":"2018","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.canrad.2024.05.007_bib0320","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/BF02305541","article-title":"Prospective cohort study of neoadjuvant treatment in conservative surgery of soft tissue sarcomas","volume":"4","author":"Temple","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0325","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/cncr.23478","article-title":"Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas","volume":"112","author":"Ryan","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2024.05.007_bib0330","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ijrobp.2009.03.015","article-title":"Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy","volume":"76","author":"MacDermed","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2024.05.007_bib0335","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1158\/1078-0432.CCR-13-1594","article-title":"Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates","volume":"19","author":"Meyer","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2024.05.007_bib0340","doi-asserted-by":"crossref","first-page":"20130258","DOI":"10.1259\/bjr.20130258","article-title":"Hypofractionated adjuvant radiation therapy of soft-tissue sarcoma achieves excellent results in elderly patients","volume":"86","author":"Soyfer","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0345","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ejso.2014.05.016","article-title":"Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas","volume":"40","author":"Kose\u0142a-Paterczyk","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0350","first-page":"60","article-title":"Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience","volume":"21","author":"K\u0131l\u0131\u00e7","year":"2017","journal-title":"Contemp Oncol (Pozn)"},{"key":"10.1016\/j.canrad.2024.05.007_bib0355","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/COC.0000000000000236","article-title":"Preoperative radiosurgery for soft tissue sarcoma","volume":"41","author":"Kubicek","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0360","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/COC.0000000000000443","article-title":"Long-term outcomes with ifosfamide-based hypofractionated preoperative chemoradiotherapy for extremity soft tissue sarcomas","volume":"41","author":"Pennington","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0365","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.canrad.2019.06.011","article-title":"Hypofractionated radiotherapy for non-metastatic bone and soft tissue sarcomas","volume":"23","author":"Yuce Sari","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2024.05.007_bib0370","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1078-0432.CCR-19-3524","article-title":"A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma","volume":"26","author":"Kalbasi","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2024.05.007_bib0375","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.adro.2020.06.024","article-title":"Early outcomes of preoperative 5-fraction radiation therapy for soft tissue sarcoma followed by immediate surgical resection","volume":"5","author":"Parsai","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0380","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3390\/jcm9082471","article-title":"Hypofractionated radiotherapy in locally advanced myxoid liposarcomas of extremities or trunk wall: results of a single-arm prospective clinical trial","volume":"9","author":"Kose\u0142a-Paterczyk","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.canrad.2024.05.007_bib0385","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/cancers13061332","article-title":"The feasibility study of hypofractionated radiotherapy with regional hyperthermia in soft tissue sarcomas","volume":"13","author":"Spa\u0142ek","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2024.05.007_bib0390","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2021.02.019","article-title":"Combined preoperative hypofractionated radiotherapy with doxorubicin-ifosfamide chemotherapy in marginally resectable soft tissue sarcomas: results of a phase 2 clinical trial","volume":"110","author":"Spa\u0142ek","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2024.05.007_bib0395","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2478\/raon-2021-0038","article-title":"Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population","volume":"55","author":"Potkrajcic","year":"2021","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0400","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2021.03.033","article-title":"Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: Safety, feasibility, and early oncologic outcomes of a phase 2 trial","volume":"159","author":"Gobo Silva","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0405","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.3390\/cancers13122981","article-title":"Efficacy and safety of hypofractionated preoperative radiotherapy for primary locally advanced soft tissue sarcomas of limbs or trunk wall","volume":"13","author":"Kose\u0142a-Paterczyk","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2024.05.007_bib0410","doi-asserted-by":"crossref","first-page":"100850","DOI":"10.1016\/j.adro.2021.100850","article-title":"Is 5 the new 25? Long-term oncologic outcomes from a phase II, prospective, 5-fraction preoperative radiation therapy trial in patients with localized soft tissue sarcoma","volume":"7","author":"Bedi","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0415","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.radonc.2021.06.027","article-title":"Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities","volume":"161","author":"Leite","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0420","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2021.05.025","article-title":"Preoperative stereotactic ablative body radiotherapy with postoperative conventional irradiation of soft tissue sarcomas: Protocol overview with a preliminary safety report","volume":"161","author":"Novikov","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0425","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S1470-2045(22)00638-6","article-title":"Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial","volume":"23","author":"Guadagnolo","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0430","doi-asserted-by":"crossref","first-page":"109439","DOI":"10.1016\/j.radonc.2022.109439","article-title":"Early outcomes of ultra-hypofractionated preoperative radiation therapy for soft tissue sarcoma followed by immediate surgical resection","volume":"180","author":"Mayo","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0435","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/j.ijrobp.2023.06.2386","article-title":"Surgical outcomes in patients treated with 5-day preoperative radiotherapy for soft tissue sarcoma","volume":"117","author":"Peterson","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2024.05.007_bib0440","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12094-023-03237-y","article-title":"Moderate hypofractionated radiation therapy and pathologic response for soft tissue sarcomas (STS) of limbs and trunk: experience from a tertiary cancer center","volume":"26","author":"Montero","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0445","doi-asserted-by":"crossref","first-page":"3735874","DOI":"10.1155\/2021\/3735874","article-title":"Evaluating thresholds to adopt hypofractionated preoperative radiotherapy as standard of care in sarcoma","volume":"2021","author":"Valle","year":"2021","journal-title":"Sarcoma"},{"key":"10.1016\/j.canrad.2024.05.007_bib0450","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canrad.2022.07.014","article-title":"Preoperative ultra-hypofractionation radiotherapy in extremity\/trunk wall soft tissue sarcoma\u00a0-\u00a0A meta-analysis of prospective studies","volume":"27","author":"Kao","year":"2023","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2024.05.007_bib0455","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/COC.0000000000000594","article-title":"Patterns of care and survival in elderly patients with locally advanced soft tissue sarcoma","volume":"42","author":"Greto","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0460","unstructured":"Jonsson Comprehensive Cancer Center. Phase II study of 5-day hypofractionated preoperative radiation therapy for soft tissue sarcomas: Expansion Cohort. clinicaltrials.gov; 2023. NCT02701153."},{"key":"10.1016\/j.canrad.2024.05.007_bib0465","unstructured":"Mayo Clinic. A phase II study of hypofractionated preoperative radiation therapy for localized, resectable soft tissue sarcoma of the extremity and superficial trunk. clinicaltrials.gov; 2023. NCT04562480."},{"key":"10.1016\/j.canrad.2024.05.007_bib0470","unstructured":"Shinohara E. Prospective observational trial of two neoadjuvant hypofractionated radiotherapy regimens followed by surgical resection in the treatment of soft tissue sarcomas. clinicaltrials.gov; 2023. NCT04506008."},{"key":"10.1016\/j.canrad.2024.05.007_bib0475","unstructured":"University of Wisconsin, Madison. Phase II trial of neoadjuvant hypofractionated radiotherapy versus conventionally fractionated radiotherapy for soft tissue sarcomas. clinicaltrials.gov; 2023. NCT05109494."},{"key":"10.1016\/j.canrad.2024.05.007_bib0480","unstructured":"Cury F. Short course preoperative radiotherapy for soft tissue sarcomas - a phase I\/II trial (PRESTO). clinicaltrials.gov; 2023. NCT04617327."},{"key":"10.1016\/j.canrad.2024.05.007_bib0485","unstructured":"Harper JL. Feasibility trial of preoperative 5-day hypofractionated radiotherapy for primary soft tissue sarcoma. clinicaltrials.gov; 2023. NCT05776667."},{"key":"10.1016\/j.canrad.2024.05.007_bib0490","doi-asserted-by":"crossref","first-page":"815","DOI":"10.6004\/jnccn.2022.0035","article-title":"Soft Tissue Sarcoma, Version 2.2022. NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"von Mehren","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.canrad.2024.05.007_bib0495","doi-asserted-by":"crossref","first-page":"109935","DOI":"10.1016\/j.radonc.2023.109935","article-title":"Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)","volume":"190","author":"Cury","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0500","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0505","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2015.12.002","article-title":"Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies","volume":"119","author":"Haas","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.05.007_bib0510","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2023.109626","article-title":"Radiotherapy innovation in rare diseases-focusing on the value of single institutional experiences for hypofractionated radiotherapy in soft tissue sarcoma","volume":"183","author":"Mayo","year":"2023","journal-title":"Radiother Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824001987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824001987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:16:58Z","timestamp":1733055418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321824001987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1278321824001987"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2024.05.007","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is hypofractionated radiotherapy used to treat soft tissue sarcomas? Assessment of practices using the NETSARC network","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2024.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}